A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNa for the Treatment of Hepatitis B

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a randomized, open-label, multicenter phase II study to evaluate the efficacy and safety of BW-20507 in combination with PEG-IFNα in CHB patients
Epistemonikos ID: 225da08072130c32a2e90c0e0e892e31b401c9e9
First added on: Aug 23, 2025